MMP: A Protein Involved in Many Biological Processes and Therapeutic Potential

Target Name: MMP

NCBI ID: P11322

Content of Review Report on MMP Target / Biomarker

MMP

Other Name(s): Stromelysin

MMP: A Protein Involved in Many Biological Processes and Therapeutic Potential

MMP (nonspecified subtype) (Stromelysin) is a protein that is expressed in various tissues throughout the body, including the brain, heart, kidneys, liver, and pancreas. It is a member of the serpins (serine proteases inhibitors) family and is responsible for blocking the proteolytic enzymes that are involved in tissue damage and inflammation.

MMP is involved in many different biological processes in the body, including cell signaling, inflammation, and pain perception. It has been shown to play a role in a variety of diseases, including cancer, neurodegenerative diseases, and autoimmune disorders.

One of the key functions of MMP is its ability to regulate the activity of other proteins that are involved in tissue damage and inflammation. MMP interacts with a variety of proteins, including serine proteases (proteases that are involved in the breakdown of extracellular matrix components), coagulation factors (proteins that help to initiate the blood clotting process), and pain receptors.

By blocking the activity of these enzymes, MMP has been shown to have a variety of therapeutic benefits. For example, in cancer, MMP has been shown to be involved in the development and progression of cancer by promoting the growth and survival of cancer cells. In neurodegenerative diseases, MMP has been shown to contribute to the development of neurodegeneration and the progression of disease. In autoimmune disorders, MMP has been shown to play a role in the development of inflammation and the progression of autoimmune disease.

In addition to its role in disease, MMP is also of interest as a drug target. Several studies have identified potential MMP inhibitors that could be used to treat a variety of diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. These compounds have been shown to be effective in preclinical studies, and further studies are being conducted to determine their safety and effectiveness in clinical trials.

Overall, MMP is a protein that plays a critical role in many different biological processes in the body. Its involvement in disease development and regulation makes it an attractive target for drug development, and further studies are being conducted to determine its potential as a therapeutic agent.

Protein Name: MMP (nonspecified Subtype)

The "MMP Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about MMP comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets